Annual EBIT
$30.17 M
+$59.54 M+202.71%
December 31, 2021
Summary
- As of February 10, 2025, LJPC annual earnings before interest & taxes is $30.17 million, with the most recent change of +$59.54 million (+202.71%) on December 31, 2021.
- During the last 3 years, LJPC annual EBIT has risen by +$222.33 million (+115.70%).
Performance
LJPC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
$4.85 M
+$2.44 M+101.54%
June 30, 2022
Summary
- As of February 10, 2025, LJPC quarterly earnings before interest & taxes is $4.85 million, with the most recent change of +$2.44 million (+101.54%) on June 30, 2022.
- Over the past year, LJPC quarterly EBIT has dropped by -$1.56 million (-24.31%).
Performance
LJPC Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
$13.97 M
-$1.56 M-10.03%
June 30, 2022
Summary
- As of February 10, 2025, LJPC TTM earnings before interest & taxes is $13.97 million, with the most recent change of -$1.56 million (-10.03%) on June 30, 2022.
- Over the past year, LJPC TTM EBIT has increased by +$583.00 thousand (+4.36%).
Performance
LJPC TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
LJPC EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +202.7% | -24.3% | +4.4% |
| 3 y3 years | +115.7% | +117.6% | +113.2% |
| 5 y5 years | +126.3% | +118.1% | +113.2% |
LJPC EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -22.0% | -50.4% | -53.7% | at low |
| 5 y | 5-year | at high | -450.5% | -71.6% | -571.6% | -53.7% | -856.9% |
| alltime | all time | at high | -737.0% | -71.6% | -2088.4% | -53.7% | -1475.7% |
La Jolla Pharmaceutical EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $4.85 M(+101.5%) | $13.97 M(-10.0%) |
| Mar 2022 | - | $2.40 M(-61.3%) | $15.53 M(-48.5%) |
| Dec 2021 | $30.17 M(-202.7%) | $6.22 M(+1143.4%) | $30.17 M(+30.5%) |
| Sep 2021 | - | $500.00 K(-92.2%) | $23.12 M(+72.7%) |
| Jun 2021 | - | $6.40 M(-62.4%) | $13.39 M(-318.0%) |
| Mar 2021 | - | $17.05 M(-2156.1%) | -$6.14 M(-79.1%) |
| Dec 2020 | -$29.37 M(-72.2%) | -$829.00 K(-91.0%) | -$29.37 M(-42.9%) |
| Sep 2020 | - | -$9.23 M(-29.6%) | -$51.40 M(-24.9%) |
| Jun 2020 | - | -$13.12 M(+112.2%) | -$68.47 M(-17.5%) |
| Mar 2020 | - | -$6.18 M(-72.9%) | -$82.96 M(-21.5%) |
| Dec 2019 | -$105.73 M(-45.0%) | -$22.86 M(-13.1%) | -$105.73 M(-15.8%) |
| Sep 2019 | - | -$26.31 M(-4.7%) | -$125.57 M(-14.6%) |
| Jun 2019 | - | -$27.61 M(-4.6%) | -$147.08 M(-13.8%) |
| Mar 2019 | - | -$28.96 M(-32.2%) | -$170.59 M(-11.2%) |
| Dec 2018 | -$192.17 M(+67.4%) | -$42.70 M(-10.7%) | -$192.17 M(+2.4%) |
| Sep 2018 | - | -$47.82 M(-6.5%) | -$187.69 M(+12.8%) |
| Jun 2018 | - | -$51.12 M(+1.2%) | -$166.36 M(+17.1%) |
| Mar 2018 | - | -$50.53 M(+32.2%) | -$142.06 M(+23.7%) |
| Dec 2017 | -$114.80 M(+46.8%) | -$38.22 M(+44.3%) | -$114.80 M(+13.3%) |
| Sep 2017 | - | -$26.48 M(-1.3%) | -$101.32 M(+5.4%) |
| Jun 2017 | - | -$26.83 M(+15.3%) | -$96.13 M(+13.2%) |
| Mar 2017 | - | -$23.27 M(-5.9%) | -$84.92 M(+8.6%) |
| Dec 2016 | -$78.19 M(+86.3%) | -$24.74 M(+16.2%) | -$78.19 M(+19.7%) |
| Sep 2016 | - | -$21.30 M(+36.4%) | -$65.31 M(+19.8%) |
| Jun 2016 | - | -$15.62 M(-5.5%) | -$54.49 M(+10.0%) |
| Mar 2016 | - | -$16.53 M(+39.4%) | -$49.54 M(+18.0%) |
| Dec 2015 | -$41.97 M(+96.7%) | -$11.86 M(+13.1%) | -$41.97 M(+13.5%) |
| Sep 2015 | - | -$10.49 M(-1.6%) | -$36.97 M(+17.2%) |
| Jun 2015 | - | -$10.66 M(+18.9%) | -$31.55 M(+25.3%) |
| Mar 2015 | - | -$8.97 M(+30.6%) | -$25.18 M(+18.0%) |
| Dec 2014 | -$21.34 M(+18.9%) | -$6.86 M(+35.6%) | -$21.34 M(+2.2%) |
| Sep 2014 | - | -$5.06 M(+18.1%) | -$20.88 M(+4.4%) |
| Jun 2014 | - | -$4.29 M(-16.5%) | -$19.99 M(+6.0%) |
| Mar 2014 | - | -$5.13 M(-19.8%) | -$18.87 M(+5.2%) |
| Dec 2013 | -$17.94 M(+67.1%) | -$6.40 M(+53.4%) | -$17.94 M(+20.0%) |
| Sep 2013 | - | -$4.17 M(+31.9%) | -$14.95 M(+5.1%) |
| Jun 2013 | - | -$3.16 M(-24.7%) | -$14.22 M(-0.4%) |
| Mar 2013 | - | -$4.20 M(+23.3%) | -$14.27 M(+32.9%) |
| Dec 2012 | -$10.74 M(+372.3%) | -$3.41 M(-1.1%) | -$10.74 M(+37.7%) |
| Sep 2012 | - | -$3.45 M(+7.3%) | -$7.80 M(+63.3%) |
| Jun 2012 | - | -$3.21 M(+378.8%) | -$4.78 M(+93.6%) |
| Mar 2012 | - | -$671.00 K(+43.1%) | -$2.47 M(+8.5%) |
| Dec 2011 | -$2.27 M(-42.1%) | -$469.00 K(+10.9%) | -$2.27 M(-3.4%) |
| Sep 2011 | - | -$423.00 K(-53.2%) | -$2.35 M(-10.6%) |
| Jun 2011 | - | -$904.00 K(+89.1%) | -$2.63 M(-0.2%) |
| Mar 2011 | - | -$478.00 K(-12.9%) | -$2.64 M(-32.8%) |
| Dec 2010 | -$3.93 M(-54.6%) | -$549.00 K(-21.8%) | -$3.93 M(-21.1%) |
| Sep 2010 | - | -$702.00 K(-22.9%) | -$4.98 M(+41.2%) |
| Jun 2010 | - | -$910.00 K(-48.5%) | -$3.52 M(+512.0%) |
| Mar 2010 | - | -$1.77 M(+10.4%) | -$576.00 K(-81.2%) |
| Dec 2009 | -$8.64 M(-85.8%) | -$1.60 M(-312.8%) | -$3.06 M(-82.2%) |
| Sep 2009 | - | $752.00 K(-63.1%) | -$17.25 M(+1444.8%) |
| Jun 2009 | - | $2.04 M(-147.9%) | -$1.12 M(-93.8%) |
| Mar 2009 | - | -$4.25 M(-73.1%) | -$17.96 M(-33.4%) |
| Dec 2008 | -$60.73 M | -$15.79 M(-193.5%) | -$26.95 M(-74.9%) |
| Sep 2008 | - | $16.89 M(-214.1%) | -$107.53 M(-2.6%) |
| Jun 2008 | - | -$14.80 M(+11.8%) | -$110.39 M(+0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | -$13.24 M(-86.3%) | -$109.89 M(+0.8%) |
| Dec 2007 | -$55.69 M(+31.9%) | -$96.38 M(-786.8%) | -$109.00 M(+355.9%) |
| Sep 2007 | - | $14.03 M(-198.1%) | -$23.91 M(-49.3%) |
| Jun 2007 | - | -$14.30 M(+15.7%) | -$47.18 M(+9.8%) |
| Mar 2007 | - | -$12.36 M(+9.4%) | -$42.97 M(+1.8%) |
| Dec 2006 | -$42.23 M(+50.8%) | -$11.29 M(+22.3%) | -$42.23 M(+13.5%) |
| Sep 2006 | - | -$9.23 M(-8.5%) | -$37.22 M(+9.4%) |
| Jun 2006 | - | -$10.09 M(-13.2%) | -$34.03 M(+12.1%) |
| Mar 2006 | - | -$11.62 M(+85.0%) | -$30.36 M(+8.4%) |
| Dec 2005 | -$28.00 M(-31.3%) | -$6.28 M(+3.8%) | -$28.00 M(-14.5%) |
| Sep 2005 | - | -$6.05 M(-5.7%) | -$32.74 M(-17.4%) |
| Jun 2005 | - | -$6.42 M(-30.7%) | -$39.63 M(-4.9%) |
| Mar 2005 | - | -$9.26 M(-16.0%) | -$41.67 M(+2.3%) |
| Dec 2004 | -$40.74 M(+3.7%) | -$11.02 M(-14.8%) | -$40.74 M(+6.6%) |
| Sep 2004 | - | -$12.94 M(+52.8%) | -$38.23 M(+18.2%) |
| Jun 2004 | - | -$8.46 M(+1.8%) | -$32.34 M(-4.6%) |
| Mar 2004 | - | -$8.32 M(-2.3%) | -$33.89 M(-13.7%) |
| Dec 2003 | -$39.29 M(-12.0%) | -$8.51 M(+20.8%) | -$39.29 M(-11.1%) |
| Sep 2003 | - | -$7.05 M(-29.6%) | -$44.21 M(-8.4%) |
| Jun 2003 | - | -$10.02 M(-27.0%) | -$48.27 M(-2.9%) |
| Mar 2003 | - | -$13.72 M(+2.2%) | -$49.70 M(+11.3%) |
| Dec 2002 | -$44.64 M(+62.4%) | -$13.43 M(+20.9%) | -$44.64 M(+16.2%) |
| Sep 2002 | - | -$11.10 M(-3.0%) | -$38.40 M(+15.4%) |
| Jun 2002 | - | -$11.45 M(+32.3%) | -$33.28 M(+15.5%) |
| Mar 2002 | - | -$8.66 M(+20.4%) | -$28.80 M(+4.8%) |
| Dec 2001 | -$27.50 M(+75.8%) | -$7.19 M(+20.3%) | -$27.50 M(+11.4%) |
| Sep 2001 | - | -$5.98 M(-14.2%) | -$24.69 M(+5.0%) |
| Jun 2001 | - | -$6.97 M(-5.1%) | -$23.51 M(+18.6%) |
| Mar 2001 | - | -$7.35 M(+67.4%) | -$19.83 M(+26.8%) |
| Dec 2000 | -$15.64 M(+57.3%) | -$4.39 M(-8.5%) | -$15.63 M(+12.6%) |
| Sep 2000 | - | -$4.80 M(+45.8%) | -$13.88 M(+22.0%) |
| Jun 2000 | - | -$3.29 M(+4.4%) | -$11.38 M(+6.5%) |
| Mar 2000 | - | -$3.15 M(+19.4%) | -$10.69 M(+8.7%) |
| Dec 1999 | -$9.94 M(+9.2%) | -$2.64 M(+14.8%) | -$9.84 M(+5.8%) |
| Sep 1999 | - | -$2.30 M(-11.5%) | -$9.30 M(+1.1%) |
| Jun 1999 | - | -$2.60 M(+13.0%) | -$9.20 M(+3.4%) |
| Mar 1999 | - | -$2.30 M(+9.5%) | -$8.90 M(0.0%) |
| Dec 1998 | -$9.10 M(+18.2%) | -$2.10 M(-4.5%) | -$8.90 M(-1.1%) |
| Sep 1998 | - | -$2.20 M(-4.3%) | -$9.00 M(+2.3%) |
| Jun 1998 | - | -$2.30 M(0.0%) | -$8.80 M(+3.5%) |
| Mar 1998 | - | -$2.30 M(+4.5%) | -$8.50 M(+10.4%) |
| Dec 1997 | -$7.70 M(-27.4%) | -$2.20 M(+10.0%) | -$7.70 M(+16.7%) |
| Sep 1997 | - | -$2.00 M(0.0%) | -$6.60 M(-15.4%) |
| Jun 1997 | - | -$2.00 M(+33.3%) | -$7.80 M(-12.4%) |
| Mar 1997 | - | -$1.50 M(+36.4%) | -$8.90 M(-15.2%) |
| Dec 1996 | -$10.60 M(+15.2%) | -$1.10 M(-65.6%) | -$10.50 M(-18.0%) |
| Sep 1996 | - | -$3.20 M(+3.2%) | -$12.80 M(+26.7%) |
| Jun 1996 | - | -$3.10 M(0.0%) | -$10.10 M(+4.1%) |
| Mar 1996 | - | -$3.10 M(-8.8%) | -$9.70 M(+7.8%) |
| Dec 1995 | -$9.20 M(-7.1%) | -$3.40 M(+580.0%) | -$9.00 M(+21.6%) |
| Sep 1995 | - | -$500.00 K(-81.5%) | -$7.40 M(-19.6%) |
| Jun 1995 | - | -$2.70 M(+12.5%) | -$9.20 M(+1.1%) |
| Mar 1995 | - | -$2.40 M(+33.3%) | -$9.10 M(-7.1%) |
| Dec 1994 | -$9.90 M | -$1.80 M(-21.7%) | -$9.80 M(+22.5%) |
| Sep 1994 | - | -$2.30 M(-11.5%) | -$8.00 M(+40.4%) |
| Jun 1994 | - | -$2.60 M(-16.1%) | -$5.70 M(+83.9%) |
| Mar 1994 | - | -$3.10 M | -$3.10 M |
FAQ
- What is La Jolla Pharmaceutical annual earnings before interest & taxes?
- What is the all time high annual EBIT for La Jolla Pharmaceutical?
- What is La Jolla Pharmaceutical annual EBIT year-on-year change?
- What is La Jolla Pharmaceutical quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for La Jolla Pharmaceutical?
- What is La Jolla Pharmaceutical quarterly EBIT year-on-year change?
- What is La Jolla Pharmaceutical TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for La Jolla Pharmaceutical?
- What is La Jolla Pharmaceutical TTM EBIT year-on-year change?
What is La Jolla Pharmaceutical annual earnings before interest & taxes?
The current annual EBIT of LJPC is $30.17 M
What is the all time high annual EBIT for La Jolla Pharmaceutical?
La Jolla Pharmaceutical all-time high annual earnings before interest & taxes is $30.17 M
What is La Jolla Pharmaceutical annual EBIT year-on-year change?
Over the past year, LJPC annual earnings before interest & taxes has changed by +$59.54 M (+202.71%)
What is La Jolla Pharmaceutical quarterly earnings before interest & taxes?
The current quarterly EBIT of LJPC is $4.85 M
What is the all time high quarterly EBIT for La Jolla Pharmaceutical?
La Jolla Pharmaceutical all-time high quarterly earnings before interest & taxes is $17.05 M
What is La Jolla Pharmaceutical quarterly EBIT year-on-year change?
Over the past year, LJPC quarterly earnings before interest & taxes has changed by -$1.56 M (-24.31%)
What is La Jolla Pharmaceutical TTM earnings before interest & taxes?
The current TTM EBIT of LJPC is $13.97 M
What is the all time high TTM EBIT for La Jolla Pharmaceutical?
La Jolla Pharmaceutical all-time high TTM earnings before interest & taxes is $30.17 M
What is La Jolla Pharmaceutical TTM EBIT year-on-year change?
Over the past year, LJPC TTM earnings before interest & taxes has changed by +$583.00 K (+4.36%)